WallStreetZenWallStreetZen

How to Buy Connect Biopharma Holdings Stock

Connect Biopharma Holdings Ltd

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation.

Connect Biopharma Holdings stock last closed at $1.61, up 21.05% from the previous day, and has increased 89.41% in one year. It has overperformed other stocks in the Biotechnology industry by 0.95 percentage points. Connect Biopharma Holdings stock is currently +200.93% from its 52-week low of $0.54, and -43.31% from its 52-week high of $2.84.

At the moment, there are 55.04M CNTB shares outstanding. The market capitalization of CNTB is $88.62M. In the last 24 hours, 344,554 CNTB shares were traded.

How to Buy Connect Biopharma Holdings Stock

Not sure how to invest in Connect Biopharma Holdings stock? Here's how.
  1. Figure out where to buy Connect Biopharma Holdings stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you choose where to buy Connect Biopharma Holdings stock.
  2. Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Fund your brokerage account: Choose your payment method and add your details.
  4. Research Connect Biopharma Holdings stock: The Connect Biopharma Holdings ticker symbol is CNTB. Is Connect Biopharma Holdings stock a good investment? Should you buy shares of CNTB? How do CNTB's underlying business fundamentals look? Do top analysts think Connect Biopharma Holdings is a good buy? Why has CNTB's stock price moved recently? (Hint: Our stock research tools can help you figure out if CNTB is a good stock to buy).
  5. Place your CNTB purchase: Decide if you will purchase CNTB shares at the current market price or use a limit order to purchase CNTB shares at a given price.
  6. Monitor your CNTB position: Create a watchlist to keep tabs on your new investment in Connect Biopharma Holdings stock.

Step 1: Figure out where to buy Connect Biopharma Holdings stock

You need a brokerage account to access the NASDAQ market and buy CNTB stock.

A brokerage account enables you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

We believe that eToro is the best brokerage. Here's why:

  • You can invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to world markets: From Tech to Healthcare, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by opening an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've chosen the best brokerage, you need to fill out some personal information so you are able to invest in CNTB today.

How to Set Up a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal details to open a new trading account.
  1. Submit your data by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you have opened your account on stock market apps, you can securely and quickly fund your account:

Watch the walkthrough below if you need help depositing funds into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Connect Biopharma Holdings stock

After you have figured out the best place to buy Connect Biopharma Holdings stock, it's critical to analyze their stock before you buy, so you truly comprehend the risk as well as the upside.

Connect Biopharma Holdings shares at a glance

CNTB Price
$1.61
1w %
28.8%
1y %
89.41%
5y %
N/A
P/E
-1.05x
P/B
0.69x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$83.71M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$88.62M
Next Earnings
Apr 15, 2024
Next Dividend
N/A

CNTB Due Diligence Checks

WallStreetZen was built to help part-time investors perform more accurate fundamental analysis.

You can see all of the due diligence checks on CNTB's stock page.

Is CNTB stock overvalued?

Investors use many financial metrics, analyses, models, and charts to gauge CNTB's true value.

Using relative valuations metrics:

  • CNTB could be undervalued based on its P/B ratio of 0.69x, relative to Biotechnology industry P/B ratio of 6.2x

You can do more valuation research on CNTB's stock here.

CNTB Financial Summary

Signs that CNTB is financially healthy:

  • CNTB has cash burn of 79988429. It has sufficient cash and short-term investments to cover this for at least one year.
  • CNTB has a low debt to equity ratio of 0.12.
  • CNTB has $130.95M in cash and short term investments. This is sufficient to cover its annual cash burn of $79.99M.
  • There are more short-term assets than long-term liabilities on the CNTB balance sheet.
  • There are more short-term assets than short-term liabilities on the CNTB balance sheet.

Is Connect Biopharma Holdings stock a Buy, Hold, or Sell, according to analysts?

Out of 1 sell side analysts who give recommendations on CNTB, the consensus analyst rating on CNTB is a Buy

It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.

You can dive deeper into what analysts are forecasting on the Connect Biopharma Holdings stock forecast page.

Metrics for Advanced CNTB Traders

SMA10
1.28
SMA20
1.27
SMA50
1.21
SMA100
1.22
SMA200
1.1
MACD
0.05
MACD Signal
0.02
MACD Histogram
0.03
RSI
67.27
Stochastic %K
82.56
Stochastic %D
68.03
StochRSI %K
87.12
StochRSI %D
73.25

Latest Insiders Trades at CNTB

Over the last year, executives and large shareholders at CNTB have not bought or sold any shares.

Research more about who owns CNTB stock here.

Does CNTB provide a stable income stream?

No, Connect Biopharma Holdings doesn't provide an income stream by paying out dividends.

What do other traders have to say about CNTB?

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Place your CNTB purchase

You have two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at a particular dollar amount limit, use a limit order.

Click the Open Trade button and eToro will place your order.

If you want more help investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Monitor your CNTB position

Now that you own some CNTB shares, you'll want to keep up with your new investment.

Put CNTB on a watchlist to get notified of the latest news about your CNTB stock.

CNTB Feed

How to Buy Stock in Connect Biopharma Holdings

To summarize, here are the 6 steps you need to take to buy Connect Biopharma Holdings stock right now:

  1. Figure out where to buy Connect Biopharma Holdings stock
  2. Sign up for a brokerage account
  3. Fund your brokerage account
  4. Research Connect Biopharma Holdings stock
  5. Place your CNTB purchase
  6. Monitor your CNTB position

If you are looking for a brokerage account, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get the latest scoop on your new investment in Connect Biopharma Holdings, create your watchlist below.

NASDAQ: CNTB
$1.61+0.28 (+21.05%)
Updated Mar 27, 2024
Open eToro Account
NASDAQ: CNTB
$1.61+0.28 (+21.05%)
Updated Mar 27, 2024
Open eToro Account

FAQ

How much does it cost to buy one Connect Biopharma Holdings share?

As of Mar 27, 2024, it costs $1.61 to buy one share of Connect Biopharma Holdings stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.81, you can buy 0.5 shares of CNTB.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Connect Biopharma Holdings stock?

According to 1 Wall Street analysts who monitor Connect Biopharma Holdings, their consensus recommendation is to buy Connect Biopharma Holdings stock.

What is the best way to buy Connect Biopharma Holdings stock?

One way to place an order for Connect Biopharma Holdings stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.